For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
12
views
1
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      378
      similar
       All similar

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Membranous Glomerulonephritis Associated with Renal Cell Carcinoma: Failure to Detect a Nephritogenic Tumor Antigen

      case-report

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A 57-year-old man with renal cell carcinoma associated with membranous glomerulonephropathy (MGN) developed a transient amelioration of the nephrotic syndrome after excision of the tumor. We tried to identify a nephritogenic tumor antigen using the immunoblotting technique in this patient with MGN, since previous studies examined the interaction between tumor antigens and IgG eluted from the kidney tissue using immunofluorescence or immunodiffusion techniques, and no studies have identified the specific tumor antigen with the immunoblotting method. In the present study, no significant immunoreactivity was noted between the IgG eluted from renal cortical tissues of the patient and renal cell carcinoma proteins. Further studies are necessary to establish the pathogenic mechanism of MGN associated with malignancy.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Cure of membranous nephropathy after resection of carcinoma.

          H Yamauchi, M Linsey, C G Biava … (1985)
          Clinical cure was effected in two patients with biopsy-proved membranous nephropathy associated with neoplasms. One had a complete histologic remission as well. The incidence of malignancy in an unselected group of patients with membranous nephropathy in our institution was 9%. Careful workup in all patients over age 40 years with membranous nephropathy should be done to exclude tumor.
          Article 0 comments Cited 3 times – based on 0 reviews     Review now
            Bookmark
            All references

            Author and article information

            Journal
            Journal ID (publisher-id): NEF
            Journal ID (nlm-ta): Nephron
            Journal ID (doi): 10.1159/issn.1660-8151
            Title: Nephron
            Publisher: S. Karger AG
            ISSN (Print): 1660-8151
            ISSN (Electronic): 2235-3186
            Publication date Subscription-year: 2002
            Publication date (Print): February 2002
            Publication date (Electronic): 30 January 2002
            Volume: 90
            Issue: 2
            Pages: 219-221
            Affiliations
            aFirst Department of Medicine, Hamamatsu University School of Medicine and Divisions of bNephrology and cUrology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, and dDepartment of Medicine, Teikyo University School of Medicine, Itabashi, Tokyo, Japan
            Article
            Publisher ID: 49047 Other ID: Nephron 2002;90:219–221
            DOI: 10.1159/000049047
            PubMed ID: 11818710
            SO-VID: 226e3b38-06fd-4e40-a5fd-9c85099c11a9
            Copyright © © 2002 S. Karger AG, Basel
            License:

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            History
            Page count
            Figures: 2, References: 15, Pages: 3
            Categories
            Subject: Short Communication

            ScienceOpen disciplines: Cardiovascular Medicine,Nephrology
            Keywords: Elution study,Immunoblotting,Renal cell carcinoma,Membranous glomerulonephropathy
            Data availability:
            ScienceOpen disciplines: Cardiovascular Medicine, Nephrology
            Keywords: Elution study, Immunoblotting, Renal cell carcinoma, Membranous glomerulonephropathy

            Comments

            Comment on this article